Published in Ann R Coll Surg Engl on September 01, 1993
Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol (2013) 1.00
Transfusion and coagulation management in liver transplantation. World J Gastroenterol (2014) 0.92
Intraoperative blood loss in orthotopic liver transplantation: The predictive factors. World J Gastrointest Surg (2015) 0.78
Perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: A cross sectional study. Asian J Transfus Sci (2013) 0.77
Preoperative predictors of blood component transfusion in living donor liver transplantation. Asian J Transfus Sci (2013) 0.77
Risk factors for intraoperative massive transfusion in pediatric liver transplantation: a multivariate analysis. Int J Med Sci (2017) 0.75
Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant (2016) 0.75
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
Solid liver tumors. Major Probl Clin Surg (1977) 2.42
Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet (1987) 2.00
Blood use in liver transplantation. Transfusion (1987) 1.63
Liver transplantation in the adult. World J Surg (1986) 1.27
Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood (1988) 1.22
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation (1989) 1.06
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc (1989) 0.95
Orthotopic liver transplantation: postoperative complications and their management. Br J Surg (1987) 0.89
Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation. Transplant Proc (1991) 0.84
In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation. Transplant Proc (1991) 0.82
Effect of massive transfusion during liver transplantation on rejection and infection. Transplant Proc (1988) 0.82
Blood bank support of a liver transplantation program. Mayo Clin Proc (1989) 0.81
Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation. Transplant Proc (1991) 0.81
Preoperative coagulation screen does not predict intraoperative blood product requirements in orthotopic liver transplantation. Transplant Proc (1989) 0.79
Identification of the nature of hemostatic failure during transplantation of the liver. Transplant Proc (1989) 0.79
Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation. Transplant Proc (1988) 0.79
Ionized calcium levels during liver transplantation. Eur J Anaesthesiol (1987) 0.78
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet (2001) 5.75
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen (2004) 2.62
Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest (1993) 2.40
Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. J Clin Oncol (2001) 2.39
Medical evacuation from Mostar. Lancet (1996) 2.37
The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol (1989) 2.27
Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med (1994) 2.21
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest (1993) 2.03
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
The selection of cases for randomised trials: a registry survey of concurrent trial and non-trial patients. The British Stomach Cancer Group. Br J Cancer (1992) 1.94
The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet (1994) 1.92
Bile duct injury following laparoscopic cholecystectomy: referral pattern and management. Br J Surg (1997) 1.81
A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen (2004) 1.81
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut (1999) 1.80
Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer (1991) 1.78
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Neurological complications following liver transplantation. Lancet (1987) 1.76
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest (1991) 1.70
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
Liver resection for colorectal metastases. Ann R Coll Surg Engl (2003) 1.66
Treatment of hydatid disease of the liver. Evaluation of a UK experience. Dig Surg (2004) 1.65
The Amadori product on protein: structure and reactions. Prog Clin Biol Res (1989) 1.61
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther (2003) 1.60
Blue calls--time for a change? Emerg Med J (2001) 1.55
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53
Hydatid liver disease as a cause of recurrent pancreatitis. J R Coll Surg Edinb (1999) 1.49
Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and piglets. Infect Immun (1984) 1.49
Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation (1998) 1.49
Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynaecol (1992) 1.47
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Delay and survival in bladder cancer. BJU Int (2002) 1.45
Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol (2003) 1.42
Cerebral aspergillosis in liver transplantation. J Clin Pathol (1990) 1.40
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. J Lab Clin Med (1994) 1.39
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Ital J Gastroenterol Hepatol (1999) 1.39
Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report. Br Med J (1980) 1.38
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg (1994) 1.36
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. J Infect Dis (1999) 1.32
Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer (1992) 1.31
Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit (1995) 1.30
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes (1991) 1.30
Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.26
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res (1996) 1.25
Biopsy findings in cases of rejection of liver allograft. J Clin Pathol (1985) 1.24
Reduction of the secretory response to Escherichia coli heat-stable enterotoxin by thiol and disulfide compounds. Infect Immun (1983) 1.21
Effect of diabetes and aging on carboxymethyllysine levels in human urine. Diabetes (1991) 1.21
An unusual case of duodenal obstruction-gangliocytic paraganglioma. J Hepatobiliary Pancreat Surg (2009) 1.21
A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer (2007) 1.20
The treatment of major liver trauma by primary packing with transfer of the patient for definitive treatment. Br J Surg (1979) 1.20
Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol (2001) 1.19
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer (2010) 1.19
Simultaneous determination of lamivudine and zidovudine concentrations in human seminal plasma using high-performance liquid chromatography and tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 1.19
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol (1999) 1.17
Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut (1992) 1.17
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol (1988) 1.16
The development of biliary "sludge" following liver transplantation. Transplant Proc (1979) 1.14
Successful liver transplantation in babies under 1 year. BMJ (1993) 1.14
Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet (1995) 1.13
Significance of positive bacterial cultures from aortic aneurysm contents. Br J Surg (1985) 1.11
Serious paracetamol poisoning and the results of liver transplantation. Gut (1994) 1.10
Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int (2000) 1.10
Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. Br J Dermatol (2008) 1.09
Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology (2001) 1.09
Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation (1995) 1.09
Portal hypertension secondary to sigmoid colon arteriovenous malformation. Clin Radiol (1990) 1.09
Technique of organ removal and fate of kidney grafts from liver donors. Transplantation (1979) 1.08
Use of grafts procured from organ transplant recipients. Transplantation (1999) 1.06
Liver transplantation for polycystic liver disease. Liver Transpl (2001) 1.06
Novel mutations in the pheA gene of Escherichia coli K-12 which result in highly feedback inhibition-resistant variants of chorismate mutase/prephenate dehydratase. Appl Environ Microbiol (1992) 1.06
Tricuspid regurgitation on echocardiography may not be a predictor of patient survival after liver transplantation. Am J Transplant (2014) 1.06
Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers. J Clin Pharmacol (1997) 1.06
Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. Br J Obstet Gynaecol (1997) 1.06
A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.05
Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells. Biochem J (2000) 1.05
Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology (1997) 1.05
Prevention of breast cancer in the context of a national breast screening programme. J Intern Med (2012) 1.05
Bile studies after liver transplantation. Ann R Coll Surg Engl (1979) 1.05
A simple model for potential use with a misclassified binary outcome in epidemiology. J Epidemiol Community Health (2004) 1.04